ArticleStem cell investigation2016

Efficient CRISPR/Cas9-based gene correction in induced pluripotent stem cells established from fibroblasts of patients with sickle cell disease.

Masahiro Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.